Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Beyond COVID: Leveraging synthetic biology to advance the potential of mRNA-based vaccines

Join us for our recorded webinar presented at SynBioBeta 2023 to explore the groundbreaking potential of synthetic biology in advancing mRNA-based vaccines.

  • Discover how Telesis Bio addresses the bottlenecks in vaccine discovery.
  • Learn about the collaboration with RNAimmune and the BioXp platform for faster vaccine screening.
  • Gain insights into the future of mRNA-based vaccines, including the potential of RNA encapsulation on the BioXp platform.


Eric Esser

Eric Esser

President, Chief Operating Officer
Telesis Bio

David Brown, PhD.

David Brown, PhD.

Associate Director,

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Your personal data is handled according to our privacy policy. In accordance with California data privacy laws, California residents may obtain information about the categories of personal information we are collecting and the purposes for which personal information is collected and used here: California Privacy Policy. In addition, if you are located within a distributor territory, you may be contacted directly by them.